Nonpharmacologic Approaches to Treating ADHD

Authors and Disclosures

Michele Dadson, PhD, Assistant Clinical Professor, Department of Psychiatry, Behavioral Sciences, and Pediatrics, George Washington University School of Medicine, Washington, DC; Clinical Psychologist, Department of Psychiatry and Behavioral Science, Children's National Medical Center, Washington, DC

Adelaide S. Robb, MD, Associate Professor, George Washington University School of Medicine, Washington, DC; Medical Director, Inpatient Psychiatry, Children's National Medical Center, Washington, DC

Disclosure: Michele Dadson, PhD, has disclosed that she has received grants for clinical research from Forest Laboratories, Inc., Johnson & Johnson Pharmaceutical Co., Otsuka Maryland Research Institute, and Pfizer Pharmaceuticals Group.

Disclosure: Adelaide S. Robb, MD, has disclosed that she has received grants for clinical research from Organon, Otsuka, Pfizer, Janssen, Eli Lilly, Abbott, Forest, and McNeil, and grants for educational activities from Otsuka. Dr. Robb has also disclosed that she has served as an advisor or consultant to McNeil and Eli Lilly, and has served on the speaker's bureau for Pfizer, Janssen, Abbott, and McNeil.